新規フッ素化薬剤化合物の合成方法 (Novel method to synthesise valuable fluorinated drug compounds)

ad

2025-02-21 シンガポール国立大学 (NUS)

シンガポール国立大学(NUS)の研究チームは、医薬品開発において重要なフッ素化合物を効率的に合成する新しい方法を開発しました。この手法は、従来の方法よりも環境に優しく、コスト効率が高いとされています。研究チームは、特定の触媒を使用して、フッ素原子を有機分子に直接導入するプロセスを確立しました。この技術により、製薬業界は新薬の開発を加速し、製造コストを削減できる可能性があります。

<関連情報>

触媒的ジフルオロカルベン挿入によりフッ素化オキセタンイソステアへのアクセスが可能に Catalytic difluorocarbene insertion enables access to fluorinated oxetane isosteres

Tong-De Tan,Fang Zhou,Kevin P. Quirion,Yu-Qi Wang,Daniel Zhi Wei Ng,Xiaohua Luo,Eric Chun Yong Chan,Peng Liu & Ming Joo Ko
Nature Chemistry  Published:20 February 2025
DOI:https://doi.org/10.1038/s41557-024-01730-7

新規フッ素化薬剤化合物の合成方法 (Novel method to synthesise valuable fluorinated drug compounds)

Abstract

Skeletal editing of heterocyclic building blocks offers an appealing way to expand the accessible chemical space by diversifying molecular scaffolds for drug discovery. Despite the recent boom in this area, catalytic strategies that directly introduce fluorine into the backbone of small-ring heterocycles remain rare owing to the challenges of strain-induced ring cleavage and defluorination. Here we describe a copper-catalysed approach for skeletal expansion of oxygen heterocycles by reaction with a difluorocarbene species generated in situ to induce carbon atom insertion. The α,α-difluoro-oxetane products are potential surrogates of oxetane, β-lactone and carbonyl pharmacophores on the basis of their computed molecular properties and electrostatic potential maps. The utility of this approach is highlighted by synthesis of various drug-like molecules and fluorinated isosteres of biologically active compounds. Experimental and computational investigations provide insight into the mechanism and the unique role of the copper catalyst in promoting both ring-opening and cyclization steps of the reaction.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました